文献速递神经肿瘤功能神经外科

ReMind 循证认知远程康复项目用于原发性脑肿瘤患者的可行性研究

Feasibility of the evidence-based cognitive telerehabilitation program Remind for patients with primary brain tumors.
PubMed 文献 · J Neurooncol · 2018-01-10

本研究将团体认知康复项目转化为基于 iPad 的 ReMind 应用,并在原发性脑肿瘤患者中开展试点研究,评估其招募、脱落、依从性和患者满意度。28 例合格患者中 15 例低级别胶质瘤或脑膜瘤患者知情同意;参与者平均完成策略训练 71%、再训练 76%,85% 评价为「好」或「优秀」,全部表示愿意推荐给其他脑肿瘤患者;试点研究提示术后通过该应用进行认知康复可行。

要点

  • ReMind 是首个面向成人脑肿瘤患者的循证认知远程康复项目。
  • 15 例低级别胶质瘤或脑膜瘤患者参与,平均完成策略训练 71%、再训练 76%。
  • 85% 患者评价干预为「好」或「优秀」,全部愿意推荐给其他脑肿瘤患者。

核心结论

  • ReMind 应用是首个面向成人脑肿瘤患者的循证认知远程康复项目,本试点研究提示术后通过该应用进行认知康复可行。

研究设计与样本

  • 试点研究,在原发性脑肿瘤患者中评估 ReMind 应用在临床(研究)环境中的可行性,包括招募、脱落、依从性和患者满意度。
  • 干预在切除术后 3 个月开始,建议患者每周投入 3 小时、持续 10 周。
  • 28 例合格患者中 15 例疑似低级别胶质瘤或脑膜瘤患者签署知情同意。

主要发现

  • 拒绝参与的最主要原因是有 7 例患者无认知主诉。
  • 参与者平均完成策略训练的 71% 和再训练的 76%。
  • 部分患者评价再训练过于简单。
  • 85% 的患者评价干预为「好」或「优秀」,全部患者表示会将该程序推荐给其他脑肿瘤患者。

临床怎么用

  • 根据患者反馈,研究组已扩充再训练内容、增加更困难的练习。
  • 研究组将在一项随机对照试验中评估 ReMind 的疗效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many patients with primary brain tumors experience cognitive deficits. Cognitive rehabilitation programs focus on alleviating these deficits, but availability of such programs is limited. Our large randomized controlled trial (RCT) demonstrated positive effects of the cognitive rehabilitation program developed by our group. We converted the program into the iPad-based cognitive rehabilitation program ReMind, to increase its accessibility. The app incorporates psychoeducation, strategy training and retraining. This pilot study in patients with primary brain tumors evaluates the feasibility of the use of the ReMind-app in a clinical (research) setting in terms of accrual, attrition, adherence and patient satisfaction. The intervention commenced 3 months after resective surgery and patients were advised to spend 3 h per week on the program for 10 weeks. Of 28 eligible patients, 15 patients with presumed low-grade glioma or meningioma provided informed consent. Most important reason for decline was that patients (7) experienced no cognitive complaints. Participants completed on average 71% of the strategy training and 76% of the retraining. Some patients evaluated the retraining as too easy. Overall, 85% of the patients evaluated the intervention as "good" or "excellent". All patients indicated that they would recommend the program to other patients with brain tumors. The ReMind-app is the first evidence-based cognitive telerehabilitation program for adult patients with brain tumors and this pilot study suggests that postoperative cognitive rehabilitation via this app is feasible. Based on patients' feedback, we have expanded the retraining with more difficult exercises. We will evaluate the efficacy of ReMind in an RCT.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. van der Linden SD, Sitskoorn MM, Rutten GM, et al. Feasibility of the evidence-based cognitive telerehabilitation program Remind for patients with primary brain tumors. J Neurooncol. 2018. PMID: 29322428. doi:10.1007/s11060-017-2738-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。